Guidelines for the evaluation of drug catalogues in medical institutions in China

Title: Guidelines for the evaluation of drug catalogues in medical institutions in China
Edition: Original
Classification: Standard guideline
Field: Others
Countries and regions: China
Guidelines users: 各级医疗卫生机构管理人员、药事管理人员、临床医生等相关环节工作者
Evidence classification method: Using GRADE method to evaluate the quality of problem evidence system
Development unit: 北京中日友好医院、朝阳医院、上海中山医院、四川大学华西医院、安徽省立医院等多家医疗机构联合制定
Registration time: 2021-07-16
Registration number: IPGRP-2021CN195
Purpose of the guideline: 完善医疗机构药品目录质量评价规范,提升医院药事管理, 促进合理用药。